MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

STAAR Surgical Co

Cerrado

SectorSalud

26.46 -1.19

Resumen

Variación precio

24h

Actual

Mínimo

26.26

Máximo

26.94

Métricas clave

By Trading Economics

Ingresos

37M

-17M

Ventas

1.7M

44M

Margen de beneficio

-37.933

Empleados

1,157

EBITDA

48M

-23M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

-0.04% downside

Dividendos

By Dow Jones

Próximas Ganancias

29 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

408M

1.3B

Apertura anterior

27.65

Cierre anterior

26.46

Noticias sobre sentimiento de mercado

By Acuity

81%

19%

357 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

STAAR Surgical Co Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

2 sept 2025, 23:07 UTC

Adquisiciones, fusiones, absorciones

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

5 ago 2025, 10:10 UTC

Adquisiciones, fusiones, absorciones

Alcon to Buy Staar Surgical for $1.5 Billion

6 oct 2025, 11:32 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical: Broadwood Presentation Recycles Flawed, Misleading, Misinformed Claims About Process and Considerations Leading Up to STAAR's Agreement With Alcon

26 sept 2025, 21:56 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22 sept 2025, 11:15 UTC

Adquisiciones, fusiones, absorciones

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16 sept 2025, 13:12 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 sept 2025, 13:12 UTC

Adquisiciones, fusiones, absorciones

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 sept 2025, 13:11 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 sept 2025, 13:10 UTC

Adquisiciones, fusiones, absorciones

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

8 ago 2025, 13:40 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 ago 2025, 05:07 UTC

Adquisiciones, fusiones, absorciones

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 ago 2025, 05:07 UTC

Adquisiciones, fusiones, absorciones

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 ago 2025, 05:07 UTC

Adquisiciones, fusiones, absorciones

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 ago 2025, 05:07 UTC

Adquisiciones, fusiones, absorciones

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 ago 2025, 05:01 UTC

Adquisiciones, fusiones, absorciones

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

Comparación entre iguales

Cambio de precio

STAAR Surgical Co Esperado

Precio Objetivo

By TipRanks

-0.04% caída

Estimación a 12 meses

Media 26.71 USD  -0.04%

Máximo 29 USD

Mínimo 18 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para STAAR Surgical Co Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

9 ratings

0

Comprar

9

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.604 / 20.07Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

No Evidence

Sentimiento

By Acuity

357 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat